During the past decade, Kliniken der Stadt Köln gGmbH Krankenhaus Merheim conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kliniken der Stadt Köln gGmbH Krankenhaus Merheim" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Bayer" with 2 trials sponsored, "Biom'Up France SAS" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken der Stadt Köln gGmbH Krankenhaus Merheim" #1 collaborator was "BeiGene" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH" with 1 trials as a collaborator and "InterMune Deutschland GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kliniken der Stadt Köln gGmbH Krankenhaus Merheim" are "Acute Respiratory Distress Syndrome" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Hemostasis" (2 trials), "Kidney Transplantation" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Kliniken der Stadt Köln gGmbH Krankenhaus Merheim" in a lesser frequency.

Most popular intervention types in "Kliniken der Stadt Köln gGmbH Krankenhaus Merheim" are "Drug" (11 trials), "Other" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "HEMOBLAST™ Bellows" (2 trials), "Placebo" (2 trials), "AEB071" (1 trials), "Abraxane (Induction)" (1 trials) and "Abraxane (Maintenance)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken der Stadt Köln gGmbH Krankenhaus Merheim" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Kliniken der Stadt Köln gGmbH Krankenhaus Merheim". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Kliniken der Stadt Köln gGmbH Krankenhaus Merheim, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken der Stadt Köln gGmbH Krankenhaus Merheim, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".